Cerebrospinal fluid volumetric MRI mapping as a simple measurement for evaluating brain atrophy

European Radiology

Volumn 26, Issue 5, 2016, Pages 1254-1262

  De Vis, J B ^a   Zwanenburg, J J ^a   van der Kleij, L A ^a   Spijkerman, J M ^a   Biessels, G J ^a   Hendrikse, J ^a   Petersen, E T ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Brain atrophy; Brain volume; Cerebrospinal fluid; Imaging; Magnetic resonance imaging

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN MAPPING; BRAIN SIZE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MEDIAL TEMPORAL LOBE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; VOLUMETRY; ATROPHY; BRAIN; BRAIN DISEASES; MIDDLE AGED; PATHOLOGY; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; TEMPORAL LOBE; YOUNG ADULT;

ADULT; ATROPHY; BRAIN; BRAIN DISEASES; CEREBROSPINAL FLUID; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ROC CURVE; TEMPORAL LOBE; YOUNG ADULT;

EID: 84941344131     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-015-3932-8     Document Type: Article

References (29)

1. Wardlaw JM, Smith EE, Biessels GJ (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12:822–38
2. Pantoni L (2010) Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 9:689–701
3. Norrving B (2008) Lacunar infarcts: no black holes in the brain are benign. Pract Neurol 8:222–28
4. Bouwman FH, Schoonenboom SN, van der Flier WM et al (2007) CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment. Neurobiol Aging 28:1070–1074
5. Scheltens P, Pasquier F, Weerts JG, Barkhof F et al (1997) Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging. Eur Neurol 37:95–99
6. Scheltens P, Leys D, Barkhof F et al (1992) Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55:967–972
7. Scheltens P, Launer LJ, Barkhof F et al (1995) Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J Neurol 242:557–560
8. Horska A, Calhoun VD, Bradshaw DH et al (2002) Rapid method for correction of CSF partial volume in quantitative proton MR spectroscopic imaging. Magn Reson Med 48:555–558
9. Qin Q (2011) A simple approach for three-dimensional mapping of baseline cerebrospinal fluid volume fraction. Magn Reson Med 65:385–391
10. Jack CR Jr, Wiste HJ, Vemuri P et al (2010) Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain 133:3336–3348
11. Vemuri P, Wiste HJ, Weigand SD et al (2009) MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology 73:294–301
12. Koedam EL, Lehmann M, van der Flier WM et al (2011) Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol 21:2618–2625
13. Donahue MJ, Lu H, Jones CK et al (2006) Theoretical and experimental investigation of the VASO contrast mechanism. Magn Reson Med 56:1261–1273
14. Stanisz GJ, Odrobina EE, Pun J et al (2005) T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med 54:507–512
15. Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43:2412–2414
16. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC. doi:10.1176/appi.books.9780890425596
17. Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17:143–155
18. R Core team. R: a language environment for statistical computing. R foundation for statistical computing, Vienna, Austria. ISBN 3-900051-07-0, url http://www.R-project.org/. 2013.
19. Aribisala BS, Valdes Hernandez MC, Royle NA et al (2013) Brain atrophy associations with white matter lesions in the ageing brain: the Lothian Birth Cohort 1936. Eur Radiol 23:1084–1092
20. Scheltens PH (2001) Structural neuroimaging of Alzheimer's disease and other dementias. Aging (Milano) 13:203–209
21. Jack CR Jr, Petersen RC, O'Brien PC et al (1992) MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 42:183–188
22. Barber R, Gholkar A, Scheltens P et al (1999) Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology 52:1153–1158
23. Bastos-Leite AJ, van der Flier WM, van Straaten EC et al (2007) The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia. Stroke 38:3182–3185
24. Laakso MP, Partanen K, Riekkinen P et al (1996) Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study. Neurology 46:678–681
25. Lehmann M, Koedam EL, Barnes J et al (2013) Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers. Neurobiol Aging 34:73–82
26. Whitwell JL, Jack CR Jr, Przybelski SA et al (2011) Temporoparietal atrophy: a marker of AD pathology independent of clinical diagnosis. Neurobiol Aging 32:1531–1541
27. van de Pol LA, Hensel A, van der Flier WM et al (2006) Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease. J Neurol Neurosurg Psychiatry 77:439–442
28. Zaharchuk G, Martin AJ, Rosenthal G et al (2005) Measurement of cerebrospinal fluid oxygen partial pressure in humans using MRI. Magn Reson Med 54:113–121
29. Zaharchuk G, Busse RF, Rosenthal G et al (2006) Noninvasive oxygen partial pressure measurement of human body fluids in vivo using magnetic resonance imaging. Acad Radiol 13:1016–24